CN1283350C - Method for preparing microcapsule by high-voltage electric field encystation and low-temperature extraction and solidification - Google Patents
Method for preparing microcapsule by high-voltage electric field encystation and low-temperature extraction and solidification Download PDFInfo
- Publication number
- CN1283350C CN1283350C CN 200410084392 CN200410084392A CN1283350C CN 1283350 C CN1283350 C CN 1283350C CN 200410084392 CN200410084392 CN 200410084392 CN 200410084392 A CN200410084392 A CN 200410084392A CN 1283350 C CN1283350 C CN 1283350C
- Authority
- CN
- China
- Prior art keywords
- electric field
- liquid
- microcapsule
- low
- ball
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种制备生物可降解缓释微胶囊的新工艺,特别涉及一种高压电场成囊低温萃取固化制备微胶囊方法。The invention relates to a new process for preparing biodegradable sustained-release microcapsules, in particular to a method for preparing microcapsules by high-voltage electric field encapsulation, low-temperature extraction and solidification.
背景技术Background technique
微胶囊化技术发展到现在已有几十年。人们发现通过微胶囊化技术用壁材包裹药物制成微球后,具有提高药物稳定性、达到缓释或控释药物及改善生物相容性等优点。然而人们早期发现的大多数天然高分子壁材不能在生物体内降解,容易引起体内积累,不适合用于静脉注射、皮下埋植,使微胶囊产品在人体中的应用受到了局限。而近年来,人们开发了人工合成生物可降解的高分子壁材,如聚乳酸(PLA)、聚乳酸-聚乙二醇共聚物(PLA-PEG)及聚乳酸聚羟基乙酸的共聚物(PLGA)等。它们具有化学稳定性高、能够在体内降解、可用于静脉注射等优点。其中PLA与PLGA已被美国FDA食品药品管理局批准为药物释放载体。Microencapsulation technology has been developed for decades. It has been found that microspheres made of drugs coated with wall materials through microencapsulation technology have the advantages of improving drug stability, achieving sustained or controlled release of drugs, and improving biocompatibility. However, most of the natural polymer wall materials discovered earlier cannot be degraded in the body and easily cause accumulation in the body. They are not suitable for intravenous injection and subcutaneous implantation, which limits the application of microcapsule products in the human body. In recent years, people have developed artificially synthesized biodegradable polymer wall materials, such as polylactic acid (PLA), polylactic acid-polyethylene glycol copolymer (PLA-PEG) and polylactic acid-polyglycolic acid copolymer (PLGA). )wait. They have the advantages of high chemical stability, can be degraded in vivo, and can be used for intravenous injection. Among them, PLA and PLGA have been approved by the US FDA Food and Drug Administration as drug release carriers.
生物可降解高分子材料由于其化学稳定性高、水溶性差而不易制备成微胶囊。目前大部分聚乳酸(PLA)、聚乳酸羟基乙酸共聚物(PLGA)生物可降解微胶囊均采用乳化分散法和相分离法制备等。溶剂蒸发法是乳化分散法中常用的制备方法,主要包括单乳液法(O/W、O/O)和双乳液法(W/O/W),单乳液法的缺点在于对水溶性药物的包封率低,一般为20%左右。而复(双)乳法(W/O/W)也是近年来常用的PLGA微胶囊制备方法。它可以有效地阻碍药物分配进入连续相,从而使包封率提高,据报道用复乳法制备的微胶囊,包封率可达40%~70%。复乳法在单乳液法的基础上已经更进了一步,然而其也存在着不足之处:①微胶囊突释严重;②微胶囊形状不规则,容易发生聚集,分散不好;③添加乳化剂与表面活性剂,蛋白类药物容易变性;④药物在水相中的流失仍然存在,包封率一般等问题。除了乳化分散法之外,主要制备技术还包括相分离(凝聚)法和喷雾干燥法等。相分离(凝聚)法制备的微胶囊颗粒易于团聚,难以实际生产应用;而采用喷雾干燥法虽然能够成功地制备出PLA、PLGA微胶囊,但由于制备过程中,微胶囊会黏附于喷雾-干燥器的内壁,这使得在喷雾-干燥过程中产物大量损失,并使产物团聚。Biodegradable polymer materials are difficult to prepare into microcapsules due to their high chemical stability and poor water solubility. At present, most of the biodegradable microcapsules of polylactic acid (PLA) and poly(lactic-co-glycolic acid) (PLGA) are prepared by emulsification dispersion method and phase separation method. The solvent evaporation method is a commonly used preparation method in the emulsification dispersion method, mainly including single emulsion method (O/W, O/O) and double emulsion method (W/O/W). The disadvantage of the single emulsion method is that it is sensitive to water-soluble drugs. The encapsulation rate is low, generally around 20%. The compound (double) emulsion method (W/O/W) is also a commonly used preparation method of PLGA microcapsules in recent years. It can effectively hinder the distribution of drugs into the continuous phase, thereby increasing the encapsulation efficiency. It is reported that the encapsulation efficiency of microcapsules prepared by double emulsion method can reach 40% to 70%. The double-emulsion method has gone one step further on the basis of the single-emulsion method, but it also has shortcomings: ①The sudden release of microcapsules is serious; ②The shape of the microcapsules is irregular, easy to aggregate, and the dispersion is not good; ③Add emulsification Agents and surfactants, protein drugs are easy to denature; ④The loss of drugs in the water phase still exists, and the encapsulation efficiency is general. In addition to the emulsification and dispersion method, the main preparation techniques also include phase separation (coagulation) method and spray drying method. The microcapsule particles prepared by the phase separation (coagulation) method are easy to agglomerate, which is difficult for practical production and application; and although the PLA and PLGA microcapsules can be successfully prepared by the spray drying method, the microcapsules will adhere to the spray-drying process during the preparation process. The inner wall of the container, which causes a large loss of product during the spray-drying process and agglomerates the product.
发明内容Contents of the invention
本发明的目的是为了克服现有技术中存在的问题,提供一种高压电场成囊低温萃取固化制备微胶囊方法来制备生物可降解材料的缓释微胶囊。将高压电场法与低温萃取法相结合,构建一种制备生物可降解微胶囊的新工艺。The purpose of the present invention is to overcome the problems existing in the prior art, and provide a method for preparing microcapsules by high-voltage electric field encapsulation, low-temperature extraction and solidification to prepare slow-release microcapsules of biodegradable materials. Combining the high-voltage electric field method with the low-temperature extraction method, a new process for preparing biodegradable microcapsules was constructed.
本发明的技术方案是,一种高压电场成囊低温萃取固化制备微胶囊方法,其方法步骤为:The technical scheme of the present invention is a method for preparing microcapsules by high-voltage electric field encapsulation and low-temperature extraction and solidification. The method steps are:
1、将芯材混悬于浓度为1%~6%(W/V)的壁材的丙酮溶液中;1. Suspend the core material in the acetone solution of the wall material with a concentration of 1% to 6% (W/V);
2、将上述混悬液通过ZL00218100.2所述的高压电场微胶囊成型装置,在装置所加电场力和推进器作用下,通过调整电场电压、调整注射器下端与液氮液面之间的距离及注射器推进速度,制成不同粒径的液球;2. Pass the above suspension through the high-voltage electric field microcapsule molding device described in ZL00218100.2, under the action of the electric field force and propeller applied to the device, adjust the distance between the lower end of the syringe and the liquid nitrogen surface by adjusting the electric field voltage and the advancing speed of the syringe to make liquid balls of different particle sizes;
3、液球滴入装置的置有醇类萃取剂和-196℃液氮的容器中将液球冻结固形成球;3. Drop the liquid ball into the container with alcohol extractant and -196°C liquid nitrogen in the device to freeze the liquid ball to form a ball;
4、将容器置于-60℃~-90℃低温环境中,利用醇类萃取剂与丙酮之间的冰点差异,使萃取剂能够先溶,而丙酮混液的冻结球缓慢溶解;4. Place the container in a low-temperature environment of -60°C to -90°C, and use the difference in freezing point between the alcohol extractant and acetone to make the extractant dissolve first, while the frozen ball of the acetone mixture dissolves slowly;
5、然后用醇类萃取剂将丙酮带走,使聚合物产生沉积,微胶囊得以固化;5. Then take away the acetone with an alcohol extractant, so that the polymer is deposited and the microcapsules are solidified;
6、固化完成之后用去离子水清洗、离心,冻干保存待测。6. After the solidification is completed, wash with deionized water, centrifuge, freeze-dry and store for testing.
本方法的实际效果是:这种方法由于在固化之前就已经将芯壁材混合物分散为一粒粒均匀的微米球,然后再进行缓慢的固化,因此,一方面不会由于液-液萃取产生的较大压力冲散微囊壳或产生大的孔隙而导致微球突释严重、包封率、载药量低;另一方面在固化之前就已将微胶囊分散,使得微胶囊固化时分散性好,不产生聚集。不管聚合物从什么方向开始沉积,从原理上都可以制备出形状规则、分散较好的微胶囊。这些特点相对于其他的方法如相分离凝聚法、复乳法等相比具有一定的优势,因这些方法对于固化过程中聚合物沉降及黏度条件的控制要求较高且不宜控制,控制不好易造成微胶囊突释严重、产生聚集、包封率与载药量下降。而本方法克服了这些方法的缺陷。另外,该方法的制备过程在无水条件下进行,对于亲水性蛋白类物质的包埋,其包封率能有比较高的水平。本方法在低温环境中作业,且不添加乳化剂与表面活性剂,对于多肽蛋白类等热敏性药物具有优越性。The actual effect of this method is: this method has already dispersed the core wall material mixture into uniform microspheres before curing, and then slowly solidifies, so on the one hand, it will not be caused by liquid-liquid extraction. The high pressure of the microcapsules breaks away the microcapsule shell or produces large pores, resulting in severe burst release of the microspheres, low encapsulation efficiency, and low drug loading; Good property, no aggregation. No matter from which direction the polymer starts to deposit, microcapsules with regular shape and good dispersion can be prepared in principle. Compared with other methods such as phase separation coagulation method and double emulsion method, these characteristics have certain advantages, because these methods have higher requirements for the control of polymer sedimentation and viscosity conditions during the curing process and are not suitable for control, and the control is not easy. It caused severe sudden release of microcapsules, aggregation, encapsulation efficiency and drug loading decreased. And this method overcomes the defective of these methods. In addition, the preparation process of the method is carried out under anhydrous conditions, and for the embedding of hydrophilic protein substances, the encapsulation efficiency can have a relatively high level. The method operates in a low-temperature environment without adding emulsifiers and surfactants, and has advantages for heat-sensitive drugs such as polypeptide proteins.
附图说明Description of drawings
图1为微胶囊成型装置示意图,Fig. 1 is the schematic diagram of microcapsule forming device,
图2为高压电场成囊低温萃取固化制备微胶囊方法流程图。Fig. 2 is a flow chart of the method for preparing microcapsules by high-voltage electric field encapsulation and low-temperature extraction and solidification.
在图1中,1.高压静电场发生器、2.高压发生器正极、3.高压发生器负极、4.注射器、5.推进器、6.支架、7.液氮、8.冻结的微球、9.冻结的乙醇In Fig. 1, 1. High-voltage electrostatic field generator, 2. Positive pole of high-voltage generator, 3. Negative pole of high-voltage generator, 4. Syringe, 5. Propeller, 6. Support, 7. Liquid nitrogen, 8. Frozen micro balls, 9. frozen ethanol
具体实施方式Detailed ways
结合附图,以质量比为1∶9的胰岛素、聚乳酸乙醇酸共聚物制备的实施例对本发明作进一步描述:In conjunction with the accompanying drawings, the present invention will be further described in the embodiment prepared by insulin and poly(lactic-co-glycolic acid) copolymer with a mass ratio of 1:9:
1、按照胰岛素∶聚乳酸羟基乙酸共聚物1∶9的比例,把胰岛素溶于3.5%(W/V)的聚乳酸羟基乙酸共聚物丙酮溶液中;1. According to the ratio of insulin: poly(lactic-co-glycolic acid) copolymer 1: 9, insulin is dissolved in 3.5% (W/V) poly(lactic-co-glycolic acid) copolymer acetone solution;
2、取200mL的塑料量杯,在底部灌入无水乙醇20ml,用-196℃的液氮将其冻结,加入液氮至所需的液面高度,把配好的胰岛素、PLGA混悬液通过高压电场的微胶囊成型装置,如图1所示,在电场力和推进器作用下,通过调整一定的电压(如3.3~3.6kV),液面距(25~35mm),及推进速度,制备出不同粒径的液球。2. Take a 200mL plastic measuring cup, pour 20ml of absolute ethanol into the bottom, freeze it with liquid nitrogen at -196°C, add liquid nitrogen to the required liquid level, and pass the prepared insulin and PLGA suspension through The microcapsule forming device of high-voltage electric field, as shown in Figure 1, is prepared by adjusting a certain voltage (such as 3.3-3.6kV), liquid surface distance (25-35mm), and propulsion speed under the action of electric field force and propeller. liquid balls of different particle sizes.
3、液球滴入装置的置有-196℃液氮塑料量杯中将液球冻结为固形球。3. Drop the liquid ball into the -196°C liquid nitrogen plastic measuring cup of the device to freeze the liquid ball into a solid ball.
4、将塑料量杯置于-88℃的低温环境中,利用乙醇与丙酮之间的冰点差异(乙醇的冰点为-117.3℃,丙酮为-94.6℃),乙醇萃取剂先溶,而冻结的丙酮混液液球由于接近冰点而缓慢溶解。4. Put the plastic measuring cup in a low-temperature environment of -88°C, using the difference in freezing point between ethanol and acetone (the freezing point of ethanol is -117.3°C, and that of acetone is -94.6°C), the ethanol extractant dissolves first, and the frozen acetone The mixed liquid globule dissolves slowly as it approaches the freezing point.
5、然后用乙醇萃取剂将丙酮带走,使聚合物产生沉积,微胶囊得以固化,固化的时间为2天。5. Then the acetone is taken away with ethanol extractant, so that the polymer is deposited, and the microcapsules are solidified, and the solidification time is 2 days.
6、固化完成之后用去离子水清洗、离心,冻干保存待测。6. After the solidification is completed, wash with deionized water, centrifuge, freeze-dry and store for testing.
从实验中知道当电场电压为3.4kV,液面距为35mm,推进速度为20mm/min,制得的胰岛素微胶囊粒径小于200μm,包封率为83.2%,载药量为8.82%,缓释为7天,基本已能满足缓释制剂的需要,解决了糖尿病患者每天因频繁注射所带来的负担。It is known from experiments that when the electric field voltage is 3.4kV, the liquid surface distance is 35mm, and the advancing speed is 20mm/min, the particle size of the prepared insulin microcapsules is less than 200μm, the encapsulation rate is 83.2%, and the drug loading is 8.82%. The release time is 7 days, which can basically meet the needs of sustained-release preparations and solve the daily burden of frequent injections for diabetic patients.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410084392 CN1283350C (en) | 2004-11-22 | 2004-11-22 | Method for preparing microcapsule by high-voltage electric field encystation and low-temperature extraction and solidification |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410084392 CN1283350C (en) | 2004-11-22 | 2004-11-22 | Method for preparing microcapsule by high-voltage electric field encystation and low-temperature extraction and solidification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634646A CN1634646A (en) | 2005-07-06 |
| CN1283350C true CN1283350C (en) | 2006-11-08 |
Family
ID=34847334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410084392 Expired - Fee Related CN1283350C (en) | 2004-11-22 | 2004-11-22 | Method for preparing microcapsule by high-voltage electric field encystation and low-temperature extraction and solidification |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1283350C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106914196A (en) * | 2017-04-11 | 2017-07-04 | 江南大学 | It is a kind of that the method for carrying water microcapsules is prepared based on liquid hoodle |
| CN108272119A (en) * | 2018-02-07 | 2018-07-13 | 南昌大学 | A kind of device preparing microcapsules by temperature control solidification |
| CN110693003A (en) * | 2019-10-23 | 2020-01-17 | 华南理工大学 | Fat-soluble vitamin-encapsulated emulsion gel and its production method based on pulsed electric field |
-
2004
- 2004-11-22 CN CN 200410084392 patent/CN1283350C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1634646A (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6318271B2 (en) | Method for producing polymer microparticles with reduced initial excess release and polymer microparticles produced by the method | |
| Gaignaux et al. | Development and evaluation of sustained-release clonidine-loaded PLGA microparticles | |
| Wang et al. | Fabrication of drug-loaded biodegradable microcapsules for controlled release by combination of solvent evaporation and layer-by-layer self-assembly | |
| JP4122053B2 (en) | Particle coating method | |
| US8409621B2 (en) | Microparticles | |
| CN101690879A (en) | Method for preparing polymer micro balls with uniform grain diameter and controllable size | |
| US20080112886A1 (en) | Engineering shape of polymeric micro- and nanoparticles | |
| Patel et al. | Microsphere as a novel drug delivery. | |
| CN101947212B (en) | Micro-embedded medicament carrier and preparation method thereof | |
| JP2007507527A (en) | Biologically active nanoparticle therapeutic factors | |
| WO2019139380A1 (en) | Vitamin c-containing polycaprolactone microsphere filler and preparation method therefor | |
| JPH06511423A (en) | Preparation of microparticles | |
| CN105106174B (en) | A kind of core-shell structure copolymer bilayer microballoon and preparation method thereof | |
| Morelli et al. | Microparticles for cell encapsulation and colonic delivery produced by membrane emulsification | |
| KR100792557B1 (en) | Nanoparticles for Protein Drug Delivery with Lipid Nucleus and Polymer Shell Structure Prepared Using Nanoencapsulation | |
| Della Porta et al. | NSAID drugs release from injectable microspheres produced by supercritical fluid emulsion extraction | |
| KR101307729B1 (en) | Injectable composition comprising microparticles with reduced initial drug release and method for preparing thereof | |
| SE518007C2 (en) | Preparation of microparticles containing biologically active compounds useful in preparation for controlled release substance, comprises biodegradable polymer in an organic solvent | |
| CN114588115A (en) | Preparation method of PLGA drug sustained-release microspheres | |
| CN1283350C (en) | Method for preparing microcapsule by high-voltage electric field encystation and low-temperature extraction and solidification | |
| Park et al. | Microencapsulation technology | |
| Park et al. | Triptorelin acetate-loaded poly (lactide-co-glycolide)(PLGA) microspheres for controlled drug delivery | |
| Stevanović | Polymeric micro-and nanoparticles for controlled and targeted drug delivery | |
| CN1257708C (en) | Modified water-soluble medicine and vaccine embedded macromolecule microsphere preparation method | |
| CN109939220B (en) | Polypeptide microsphere with quick-release and slow-release effects and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061108 |